Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001719885 | SCV000250615 | likely benign | not provided | 2020-09-02 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003764844 | SCV000754959 | benign | FG syndrome | 2023-05-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345427 | SCV002652455 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2022-01-07 | criteria provided, single submitter | clinical testing | The p.I190V variant (also known as c.568A>G), located in coding exon 5 of the MED12 gene, results from an A to G substitution at nucleotide position 568. The isoleucine at codon 190 is replaced by valine, an amino acid with highly similar properties. In one study, authors used in silico models and computational methods to determine potential pathogenicity of this alteration, which remains unclear (Banaganapalli B et al. J. Cell. Biochem., 2016 09;117:2023-35). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
ITMI | RCV000121332 | SCV000085506 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |